Upward Trend In Largest Psychedelic Compound-Based R&D Stocks Continues

The 6 largest  psychedelic compound-based research & development stocks are ranked below as to their performances this week, in June, in May, and YTD:

  1. Atai (ATAI); up 15.4% this week; down 3.9% in June; down 6.3% in May; down 33.3% YTD
    • focused on the use of ketamine*, DMT* and ibogaine*.  Go here for much more extensive information on Ketamine and here for much more extensive information on DMT.
    • current short interest: 3.6% - A high short interest signals that investors have become more bearish and may be getting ready to sell and, as such, that it may be time to liquidate a long position.
    • current price/share: $1.72
    • Read: Atai Life Sciences: Long On Money; Short On Success
  2. Mind Medicine (MNMD): up 8.2% this week; up 0.8% in June; down 7.3% in May; up 63.8% YTD
  3. Compass Pathways (CMPS): up 5.3% this week; up 12.8% in June; down 8.5% in May; up 6.0% YTD
    • focused on the use of psilocybin* (magic mushrooms) in their research. Go here for much more extensive information on Psilocybin.
    • current short interest: 14.9%
    • current price/share: $8.28
  4. Seelos (SEEL): up 3.4% this week; up 29.0% in June; up 34.8% in May; up 84.6% YTD
  5. GH Research (GHRS): up 0.3% this week; up 6.9% in June; up 32.1% in May; up 24.4% YTD
    • is primarily focused on the use of mebufotenin*, the new International non-proprietary name for 5-MeO-DMT, which stands for 5-MethOxy-N,N-DiMeThyltryptamine but is better known by its nickname, “The Toad”,
    • current short interest: 9.8%
    • current price/share: $11.87
    • Read: GH Resources: Focus On Treatment-Resistant Depression Paying Off 
  6. Incannex Healthcare (IXHL): down 3.2% this week; down 2.7% in June; down 13.0% in May; down 34.6% YTD

*Read 10 Psychedelic Substances And The 36 Companies Researching Them for a description of each of the psychedelic-based compounds mentioned in this article.


The munKNEE Psychedelic Drug Stocks Index was up 3.4% this week; up 7.1% in June, up 6.3% in May; and up 11.4% YTD.

If you are interested in this category, consider the  AdvisorShares Psychedelic ETF (PSIL) which consists of 23 such stocks - but keep in mind that the vast majority have market capitalizations of $50M or less (i.e. are nano-caps). It was down 1.1% this week; up 8.2% in June; down 1.7% in May and is down 1.1% YTD.

More By This Author:

Only 20% Of AI-Related Stocks Are In Bubble Mode
Conservative "Cannabis" Stock Index Flat This Week
Canopy Growth Dragged Down The Canadian Cannabis LPs Index Again This Week

Disclosure: None

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample  more

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.